26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
TriviumVet:
CEO Louise Grubb won Entrepreneur of The Year at the 2021 Waterford Business Awards.
9th March
A great celebration for our female led company as our CEO Louise Grubb has won Entrepreneur of The Year at the 2021 Waterford Business Awards. Louise Grubb, founder and CEO of...
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
1st February
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community...
Recent visit with our Researchers at North Carolina State University College of Veterinary Medicine.
31st January
Our CEO Louise Grubb and CTO Stuart Fitzgerald were delighted to catch up with Dean Kate Meurs and many of our wonderful researchers at North Carolina State University College of...
TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.
10th November
Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing...
TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – to treat dilated cardiomyopathy in dogs.
10th November
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...
IHS Markit Article – TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps
15th September
Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is...
FDA’s Center for Veterinary Medicine deems TriviumVet’s feline HCM program eligible for expanded conditional approval pathway
14th September
TriviumVet™ are delighted to announce that the Food and Drug Administration’s Center for Veterinary Medicine has determined that our feline hypertrophic cardiomyopathy (HCM)...
TriviumVet announce collaboration with the Dog Aging Project
16th April
TriviumVet, today announced an exciting research collaboration with the Dog Aging Project, TRIAD Trial. What is the Dog Aging Project? The Dog Aging Project is an innovative...
TriviumVet announce publication of recent research into gastric acid suppression in dogs
11th March
TriviumVet are delighted to announce the publication of a clinical study assessing our first product in development, a gastric acid suppressant to treat gastric ulceration in dogs.
TriviumVet advance their first feline product, a potential treatment for HCM in cats
21st January
TriviumVet commence clinical study of first-in-disease treatment for HCM in cats We are delighted to announce the initiation of a ground-breaking clinical study in client-owned...
TriviumVet:
TriviumVet represented at the VMX Conference presented by North American Veterinary Community
1st February
It was great to have TriviumVet represented by our CEO Louise Grubb and CTO Stuart Fitzgerald at a very informative VMX conference presented by North American Veterinary Community...
Recent visit with our Researchers at North Carolina State University College of Veterinary Medicine.
31st January
Our CEO Louise Grubb and CTO Stuart Fitzgerald were delighted to catch up with Dean Kate Meurs and many of our wonderful researchers at North Carolina State University College of...
TriviumVet represented by Susan Kennedy at the information day for SMEs in the veterinary medicines sector organised by European Medicines Agency.
10th November
Susan presented TriviumVet’s experience of receiving scientific advice from the EMA. The event gave attendees the opportunity to hear first-hand experience of SME’s and marketing...
TriviumVet work with Texas A&M University on a clinical trial evaluating a new drug – to treat dilated cardiomyopathy in dogs.
10th November
TriviumVet are delighted to be working with Texas A&M University on this exciting clinical trial. Press Release by Texas A&M University: Dilated cardiomyopathy (DCM) is the second...
IHS Markit Article – TriviumVet gearing up for pet pipeline launches to bridge therapeutic gaps
15th September
Ireland’s TriviumVet is a therapeutics and diagnostics start-up targeting a range of unmet needs in companion animal health. Having weathered the COVID-19 pandemic, the company is...
FDA’s Center for Veterinary Medicine deems TriviumVet’s feline HCM program eligible for expanded conditional approval pathway
14th September
TriviumVet™ are delighted to announce that the Food and Drug Administration’s Center for Veterinary Medicine has determined that our feline hypertrophic cardiomyopathy (HCM)...
TriviumVet announce collaboration with the Dog Aging Project
16th April
TriviumVet, today announced an exciting research collaboration with the Dog Aging Project, TRIAD Trial. What is the Dog Aging Project? The Dog Aging Project is an innovative...
TriviumVet announce publication of recent research into gastric acid suppression in dogs
11th March
TriviumVet are delighted to announce the publication of a clinical study assessing our first product in development, a gastric acid suppressant to treat gastric ulceration in dogs.
TriviumVet advance their first feline product, a potential treatment for HCM in cats
21st January
TriviumVet commence clinical study of first-in-disease treatment for HCM in cats We are delighted to announce the initiation of a ground-breaking clinical study in client-owned...